AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $184,066 | -11.3% | 18,555 | +5.3% | 0.00% | 0.0% |
| Q1 2024 | $207,552 | -14.9% | 17,619 | +2.5% | 0.00% | -33.3% |
| Q4 2023 | $243,855 | +21.5% | 17,185 | +4.1% | 0.00% | 0.0% |
| Q3 2023 | $200,725 | -2.8% | 16,507 | +0.4% | 0.00% | 0.0% |
| Q2 2023 | $206,562 | +16.5% | 16,446 | +2.9% | 0.00% | 0.0% |
| Q1 2023 | $177,274 | -7.9% | 15,985 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $192,564 | +18.9% | 15,771 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $162,000 | +1.2% | 15,508 | +4.1% | 0.00% | 0.0% |
| Q2 2022 | $160,000 | +35.6% | 14,903 | +19.2% | 0.00% | +50.0% |
| Q1 2022 | $118,000 | -18.6% | 12,507 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $145,000 | +22.9% | 12,566 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $118,000 | -13.9% | 12,372 | -12.7% | 0.00% | -33.3% |
| Q2 2021 | $137,000 | -23.5% | 14,171 | +19.4% | 0.00% | -40.0% |
| Q2 2020 | $179,000 | – | 11,866 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
| Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
| Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
| STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
| CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
| Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
| GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
| Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
| AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
| Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |